Cost Guide · 2026
Semaglutide Cost with Medicare: 2026 Pricing
For patients considering Semaglutide, cost is often the deciding factor. Here is a comprehensive breakdown of what Semaglutide costs with medicare in 2026, including savings strategies that can dramatically reduce out-of-pocket expenses.
⚠️ Medical Disclaimer
This page is for educational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs. Discuss all treatment decisions with a licensed healthcare provider who knows your complete medical history. Individual results vary significantly from clinical trial averages.
List Price
$1349/month
With Insurance
$25/month (with approved coverage)
Prior Auth
Yes — required by most plans
Semaglutide + Medicare: What to Expect
Medicare Part D may cover GLP-1 medications for type 2 diabetes but has historically excluded coverage for obesity alone. The Inflation Reduction Act and potential CMS rule changes may expand coverage — check Medicare.gov for current status.
Price Breakdown by Coverage Type
| Coverage Type | Typical Monthly Cost | Notes |
|---|---|---|
| List price (cash) | $1349/month | Without any coverage or discount |
| Commercial insurance | $25/month (with approved coverage) | Highly variable by plan and formulary tier |
| Manufacturer savings card | As low as $25–$50/month (commercially insured) | Eligibility restrictions apply; not for Medicare/Medicaid patients |
| Compounded | $299/month | Availability depends on FDA shortage status |
Prior Authorization Requirements
Prior authorization (PA) is required by most commercial insurers and Medicare Part D plans. The PA process typically requires:
- Diagnosis of obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity
- Documentation of previous lifestyle modification attempts
- Sometimes: failure of prior obesity pharmacotherapy (step therapy)
- Sometimes: specific HbA1c criteria for diabetic indications
Prior authorization approval rates vary significantly by payer. Your prescriber's office can assist with the PA process.
Manufacturer Savings Programs
Savings card eligibility: Commercially insured patients (not Medicare/Medicaid) may qualify for significant savings through manufacturer programs. Contact the manufacturer directly for current program details and income eligibility thresholds.
Cost-Reduction Strategies
- GoodRx: Compare pharmacy prices — variation of $50–$150/month between pharmacies is common
- 90-day supply: Many pharmacies and mail-order programs offer 10–20% savings on 90-day fills
- Patient assistance programs: Income-based programs may provide the medication at low or no cost for qualifying patients
- Compounded alternatives: When brand is on FDA shortage, licensed 503B compounding pharmacies may offer significantly lower prices
- HSA/FSA funds: Pre-tax dollars can be used for prescription costs — effectively reducing cost by your marginal tax rate
- Clinical trials: Eligible patients may receive medication at no cost through clinical trial participation — see ClinicalTrials.gov
Semaglutide 2026 Cost Outlook
GLP-1 medication pricing continues to evolve. Key factors affecting Semaglutide costs in 2026 include: increased formulary competition from newer agents (tirzepatide, pending approvals), potential Medicare negotiation under the Inflation Reduction Act, and the ongoing consolidation of the compounding pharmacy landscape following FDA shortage delisting.
💰 Cost Estimator Calculator
Enter your specific insurance details to get a personalized cost estimate for Semaglutide and alternatives.
Open Cost Estimator →